Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
- Journal Article
Summary
This research examines the effective usage and understanding of pharmacology and pharmacokinetics of drugs (like digitalis, digoxin, etc.) used to treat cardiac disease in horses. It stresses the importance of understanding the applied pharmacology, dosage recommendations, potential toxicity, and practical considerations before efficient usage.
Understanding pharmacology and pharmacokinetics
The article stresses the importance of understanding the pharmacology, which is the study of how drugs interact with a living body, and pharmacokinetics, which is the study of how a drug is absorbed, distributed, metabolized, and excreted by the body. This knowledge is key to effectively treating cardiovascular disease in horses. Specific drugs mentioned include digitalis and digoxin.
- Digitalis and digoxin: These drugs have been traditionally used to treat various heart conditions in humans and are being used in equine veterinary practice.
Treatment of congestive heart failure
Concentrates on the use of certain drugs to treat congestive heart failure in horses. These include calcium solutions, dopamine, and dobutamine.
- Calcium solutions: These help maintain proper heart rhythm.
- Dopamine and dobutamine: Used to increase heart rate and strength of heart muscle contraction, which can increase cardiac output and improve blood supply.
Dealing with arrhythmias
Indicates that the drugs quinidine, procainamide, lidocaine, and propranolol are used to treat a variety of supraventricular and ventricular arrhythmias in horses.
- Supraventricular and ventricular arrhythmias: These are abnormal heart rhythms that originate either in the upper or lower chambers of the heart.
- Quinidine, procainamide, lidocaine, and propranolol: These drugs work by correcting irregular heartbeats.
Furosemide for Edema and Diuresis
Furosemide, a highly potent loop diuretic, is mentioned as a standard treatment to eliminate edema and promote diuresis in horses suffering from heart disease.
- Edema: Swelling caused by excess fluid trapped in body’s tissues, which can result from heart disease.
- Diuresis: The increased production of urine, which can prevent fluid buildup in horses with heart issues.
- Furosemide: A potent diuretic that helps get rid of excess fluid and salt in the body.
Need for thorough understanding
Emphasizes the absolute necessity for practitioners to have a deep understanding of applied pharmacology, dosage recommendations, toxicity, and practical considerations before these drugs can be used effectively in treating horses with heart disease.
Cite This Article
Publication
Researcher Affiliations
MeSH Terms
- Administration, Oral
- Animals
- Arrhythmias, Cardiac / drug therapy
- Arrhythmias, Cardiac / veterinary
- Cardiovascular Agents / metabolism
- Cardiovascular Agents / pharmacology
- Cardiovascular Agents / therapeutic use
- Digoxin / pharmacology
- Digoxin / therapeutic use
- Diuretics / therapeutic use
- Dobutamine / pharmacology
- Dobutamine / therapeutic use
- Dopamine / pharmacology
- Dopamine / therapeutic use
- Drug Administration Schedule
- Edema / drug therapy
- Edema / etiology
- Heart Diseases / drug therapy
- Heart Diseases / metabolism
- Heart Diseases / physiopathology
- Heart Diseases / veterinary
- Heart Failure / complications
- Heart Failure / therapy
- Heart Failure / veterinary
- Heart Rate / drug effects
- Hemodynamics / drug effects
- Horse Diseases / drug therapy
- Horse Diseases / metabolism
- Horse Diseases / physiopathology
- Horses
- Injections, Intravenous
- Lidocaine / pharmacology
- Lidocaine / therapeutic use
- Procainamide / pharmacology
- Procainamide / therapeutic use
- Propranolol / pharmacology
- Propranolol / therapeutic use
- Quinidine / pharmacology
- Quinidine / therapeutic use
Citations
This article has been cited 1 times.- Vitale V, Vezzosi T, Di Franco C, Briganti A, Tognetti R, Conte G, Bucchioni E, Sgorbini M. Equine echocardiography: Can dobutamine infusion correct alterations due to sedation with alpha-2 agonists?. PLoS One 2022;17(10):e0276256.